Zavegepant for Acute Migraine Treatment - 8422, 11.05 AM
Zavegepant, a future nasal spray acute migraine treatment, maybe by 2023. Application to the FDA for approval has been made.
Zavegepant, a future nasal spray acute migraine treatment, maybe by 2023. Application to the FDA for approval has been made.